tiprankstipranks
Intellia Therapeutics (NTLA)
NASDAQ:NTLA

Intellia Therapeutics (NTLA) Income Statement

2,498 Followers

Intellia Therapeutics Income Statement

Last quarter (Q3 2023), Intellia Therapeutics's total revenue was $11.99M, a decrease of -9.60% from the same quarter last year. In Q3, Intellia Therapeutics's net income was $-122.08M. See Intellia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Revenue
$ 51.77M$ 52.12M$ 33.05M$ 57.99M$ 43.10M$ 30.43M
Cost of Revenue
------
Gross Profit
$ 51.77M$ 52.12M$ 33.05M---
Operating Expense
$ 289.93M$ 510.29M$ 300.90M$ 194.58M$ 149.47M$ 121.30M
Operating Income
$ -485.49M$ -458.16M$ -267.85M$ -136.58M$ -106.37M$ -90.87M
Net Non Operating Interest Income Expense
$ 42.73M$ 8.54M$ 1.28M$ 2.35M$ 6.83M$ 5.53M
Other Income Expense
$ 4.11M$ 26.20M$ 3.45M---
Pretax Income
$ -457.36M$ -475.82M$ -270.02M$ -134.23M$ -99.53M$ -85.34M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
$ -14.15M$ -11.08M$ -1.32M---
Net Income Common Stockholders
$ -455.88M$ -475.82M$ -270.02M$ -134.23M$ -99.53M$ -85.34M
Basic EPS
$ -7.30M$ -6.16$ -3.78$ -2.40$ -2.11$ -1.98
Diluted EPS
$ -5.33$ -6.16$ -3.78$ -2.40$ -2.11$ -1.98
Basic Average Shares
$ 341.57M$ 76.97M$ 70.89M$ 55.99M$ 47.25M$ 43.07M
Diluted Average Shares
$ 341.57M$ 76.97M$ 70.89M$ 55.99M$ 47.25M$ 43.07M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 289.93M$ 510.29M$ 300.90M$ 194.58M$ 149.47M$ 121.30M
Net Income From Continuing And Discontinued Operation
$ -459.01M$ -474.19M$ -270.02M$ -134.23M$ -99.53M$ -85.34M
Normalized Income
$ -195.32M$ -362.42M-$ -134.23M$ -99.53M$ -85.34M
Interest Expense
------
EBIT
$ -462.71M$ -475.82M$ -270.02M$ -136.58M$ -106.37M$ -90.87M
EBITDA
$ -232.75M$ -464.25M$ -255.52M$ -130.27M$ -100.78M$ -86.41M
Currency in USD

Intellia Therapeutics Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis